Protean e-Gov Technologies Fair Value
Protean e-Gov Technologies (PROTEAN) average fair value is ₹656.5 across 6 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹598.9 (+9.62%), fair value range ₹125.58–₹1669.71. For live price and a broader fundamental view, visit PROTEAN screener.
Fair Value Analysis Export
PROTEAN Fair Value vs Current Price — Valuation Summary
PROTEAN average fair value, fair value range, price gap and valuation status across 6 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF).
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
Discounted Cash Flow (DCF)
PROTEAN Fair Value Analysis — Data Sources & Coverage
Protean e-Gov Technologies financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year. Check Protean e-Gov Technologies marketcap in USD to track the company's total market size over time.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
PROTEAN vs Information Technology Sector Peers — P/E, P/B & Market Cap
Protean e-Gov Technologies P/E ratio, P/B ratio and market capitalisation vs Information Technology sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Excelsoft Technologies | EXCELSOFT | 19.77 | 1.48 | ₹866 |
| Covance Softsol | COVANCE | 10.75 | 2.19 | ₹367 |
| Fractal Analytics | FRACTAL | 53.35 | 4.8 | ₹15,219 |
| ObjectOne Information Sy… | OONE | 4.13 | 0.42 | ₹7 |
| Coforge | COFORGE | 36.8 | 2.42 | ₹51,979 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.